Literature DB >> 8381566

ATP depletion is associated with cytotoxicity of a novel lipid regulator in guinea pig adrenocortical cells.

L A Vernetti1, J R MacDonald, G H Wolfgang, M A Dominick, D G Pegg.   

Abstract

A novel lipid regulator (PD132301-2) produces degeneration and necrosis of adrenal fasciculata in guinea pigs. Primary adrenocortical cell cultures from male Hartley guinea pigs were utilized to investigate potential mechanisms of this toxicity. Concentration-dependent loss of viability, measured by neutral red (NR) accumulation or MTT reduction, was observed within 6 hr at concentrations of 0.01 to 10 microM PD132301-2. At 10 microM, NR and MTT indices were 50% of those of control after 6 hr exposure. Maximal decreases in NR and MTT indices to 20% of control values occurred by 24 hr at > or = 1 microM PD132301-2. Adenine nucleotide analysis after PD132301-2 challenge indicated that ATP depletion preceded loss of viability. At 10 microM PD132301-2, ATP levels were 80% of those of control after 30 min and 25% of those of control after 6 hr. Supplementation of glucose-free buffer with 20 mM fructose protected adrenocortical cells from PD132301-2-induced toxicity. Fructose protection was blocked by inhibiting glycolysis with 1 mM sodium fluoride. Pretreatment of cultures with 100 microM metyrapone, an inhibitor of cytochrome P-450, did not block cytotoxicity induced by 10 microM PD132301-2, but did block cytotoxicity of 100 microM o,p'-DDD. In adrenocortical mitochondrial preparations, inhibition of respiration by PD132301-2 was site II-specific. Both state 3 and state 4 respiration were inhibited 50-75% at 1-30 microM PD132301-2. Thus, ATP depletion resulting from direct inhibition of mitochondrial respiration is a critical early event in adrenocortical cytotoxicity of PD132301-2.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381566     DOI: 10.1006/taap.1993.1005

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  8 in total

Review 1.  Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials.

Authors:  Rosario Pivonello; Rosario Ferrigno; Maria Cristina De Martino; Chiara Simeoli; Nicola Di Paola; Claudia Pivonello; Livia Barba; Mariarosaria Negri; Cristina De Angelis; Annamaria Colao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-08       Impact factor: 5.555

2.  ATP assay on cell monolayers as an index of cytotoxicity.

Authors:  A Castaño; J V Tarazona
Journal:  Bull Environ Contam Toxicol       Date:  1994-08       Impact factor: 2.151

3.  Lipid-lowering effects of WAY-121,898, an inhibitor of pancreatic cholesteryl ester hydrolase.

Authors:  B R Krause; D R Sliskovic; M Anderson; R Homan
Journal:  Lipids       Date:  1998-05       Impact factor: 1.880

4.  A possible mechanism for the cytotoxicity of a polyacetylenic alcohol, panaxytriol: inhibition of mitochondrial respiration.

Authors:  H Matsunaga; T Saita; F Nagumo; M Mori; M Katano
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

5.  Modulation of adrenal cell functions by cadmium salts: 3. Sites affected by CdCl2 during stimulated steroid synthesis.

Authors:  O P Mgbonyebi; C T Smothers; J J Mrotek
Journal:  Cell Biol Toxicol       Date:  1994-02       Impact factor: 6.691

6.  ATR-101 disrupts mitochondrial functions in adrenocortical carcinoma cells and in vivo.

Authors:  Yunhui Cheng; Raili Emilia Kerppola; Tom Klaus Kerppola
Journal:  Endocr Relat Cancer       Date:  2016-02-03       Impact factor: 5.678

Review 7.  Acyl-Coenzyme A: Cholesterol Acyltransferase (ACAT) in Cholesterol Metabolism: From Its Discovery to Clinical Trials and the Genomics Era.

Authors:  Qimin Hai; Jonathan D Smith
Journal:  Metabolites       Date:  2021-08-14

8.  Drug repurposing using high-throughput screening identifies a promising drug combination to treat adrenocortical carcinoma.

Authors:  Antonio M Lerario; Gary D Hammer
Journal:  Oncotarget       Date:  2018-09-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.